https://www.mynewsdesk.com/no/astrazeneca/documents Mynewsdesk nyhetsstrøm direkte fra kilden https://www.mynewsdesk.com/no/astrazeneca/documents https://www.mynewsdesk.com/assets/graphics/logos/logo-small-3b24ab90.png 128 23 sv 15 Mon, 09 May 2022 13:44:53 +0200 HER2-positiv brystkreft https://www.mynewsdesk.com/no/astrazeneca/documents/infographics-her2-positiv-brystkreft-422383?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=document https://www.mynewsdesk.com/no/astrazeneca/documents/infographics-her2-positiv-brystkreft-422383?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=document AstraZeneca AB Mon, 09 May 2022 13:42:39 +0200 Generelt om brystkreft https://www.mynewsdesk.com/no/astrazeneca/documents/infographics-brystkreft-generelt-422380?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=document https://www.mynewsdesk.com/no/astrazeneca/documents/infographics-brystkreft-generelt-422380?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=document AstraZeneca AB